Revilab SL 09 is a next-generation peptide complex designed specifically for men. This advanced formula targets the key systems that matter most: sexual, hormonal, genitourinary, and neuroendocrine health.
Subscribe to mailing and get the latest news and discounts of our store.>
Peptides takes care of product quality and safety
We keep up with the times, take care of the safety of our preparations and the health of consumers. The main task of Peptides is to give everyone the opportunity to preserve and strengthen their health, improve the quality of life using natural, effective, high-quality and modern preparations.
That is why we decided to abandon the use in the production of our parapharmaceuticals and remove titanium dioxide from the composition. Titanium dioxide (Е171) - a food additive (dye) with whitening properties, is widely used in many areas: pharmacology, cosmetology, food industry. Most often, it is used as a bleach in tablets and capsules.
Already today there are a number of preparations on sale with these changes (cytomaxes, cytogens), which means that now they are in transparent capsules! Soon, all encapsulated peptide bioregulators, as well as a number of therapeutic preparations, will be released in this form.
We approach the production of our products with great responsibility and want it to be as useful for consumers as possible, so we carry out large-scale scientific and research work, constantly introduce innovative technologies in production.
Kidney diseases are a global health challenge, affecting 10-20% of the population and significantly impacting quality of life. Therefore, our new research article in the SIC project focuses on the use of peptide bioregulators (such as Pielotax, Ovagen, and Renefort) in the prevention and treatment of kidney pathologies.
We are pleased to invite you to explore a new article from the Scientific Information Center on male health and peptide bioregulators — Application of peptide bioregulators to maintain the function of the male reproductive system.
In a recently conducted scientific study within the framework of the SIC project «Clinical and experimental studies of the efficacy of vascular peptides», an in-depth review of the primary aspects of the aforementioned topic will be conducted. The aspects addressed include:
